My Ultimate Sign-in System Made Me Invincible Chapter 465 Hands Are Tied (3)

The urgent assembly in Moscow was called together at an unprecedented pace, yanking ministers and military leaders away from their nightly duties with scant details except for "pressing national security issue."

The chamber was fortified, devoid of windows, and filled with individuals who knew full well that discussions here stayed confined unless given explicit permission to escape.

The Defense Minister began, his tablet showing the Medical Nanites reveal translated into Russian. "This alters the entire strategic landscape. We've kept tabs on Nova Technologies ever since the Lucid device surfaced. Our intel agencies have uncovered zilch. No traceable supply lines. No pinpointable production sites. No followable staff. And now they unveil medical tech that renders our whole defense medical team outdated and boast about a space-based setup we never spotted."

The Foreign Minister bent ahead. "The US got a heads-up early. Five hours. Plenty of time to hold their crisis sessions prior to the worldwide reveal. That reveals volumes about ties between Nova Technologies and Washington."

"It shows they've got a private line," another voice chimed in. "Probably via Whitlock. But five hours isn't true teamwork. It's mere politeness. The Americans are fumbling in the dark just like us."

A thick quiet ensued, laden with unspoken ramifications nobody dared voice outright.

The leader of the national tech advancement firm spoke with caution. "Our labs have strived to dissect the Lucid device's features from the very start. Advances have been... minimal. Just the wireless linking runs on concepts beyond our grasp. Tossing in medical nanites—ones capable of rebuilding organs and mending brain injuries—signals we're facing not a step-by-step tech edge. It's a divide spanning entire civilizations."

"Can we obtain this tech?" The query arose from a figure with an intentionally obscure rank, but his attendance hinted at SVR ties.

"Via what means?" the Defense Minister queried. "Industrial spying requires something tangible to pilfer. We lack even a clue on their research spots. The extraterrestrial site points to orbital workings, yet our orbital surveillance missed any takeoffs that could build such setups. They're either blasting off from blind spots or wielding detection-proof tech."

The spy chief's face implied he'd probed various routes and hit dead ends everywhere. "We've tried luring their employees. No employees exist for us to lure. We've chased their money trails. Deals weave through unbreakable networks. We've hunted for their bases. They don't show up in normal ways."

"How about those clinical tests?" the Foreign Minister proposed. "They're welcoming global watchers. We could dispatch envoys. Gain entry to the site. Grasp the tech up close."

"Merely as watchers," the Defense Minister stated bluntly. "Without chances to snag specimens, probe core systems, or snag know-how. We'd merely spectate as they showcase feats beyond our mimicry."

"It's still ahead of our current nothing."

"Is it? Or does it just spotlight our tech shortcomings brighter?"

The group took in that point sans straight reply.

The economics expert voiced his initial input. "The bigger issue for strategy lies in how this shifts our world standing. We've held sway via fuel sales, armed strength, and power projection nearby. Medical nanites erode every pillar. Fuel loses worth when tech surges past what we can rival. Armed might fades when foes wield healing that turns losses into choices. And nearby sway crumbles when we can't supply partners with vital tech available from others."

"You mean we forfeit key edges in various fields at once."

"I mean that should this tech deliver as promised, the world setup realigns around those holding the keys to it. And we hold none. We lack even a route to hold any."

Yet another extended hush.

The top figure, who'd observed silently till now, shifted ahead. "Our stance stands firm. We join the trial watching. We keep ties with groups ready to bridge talks. We push on with studies for matching tech, slim odds or not. And we absolutely avoid— no matter what— moves seen as aggressive against a group we don't fathom and can't oppose."

He scanned the space. "We've tackled tech shortfalls in the past. We've always adapted, exploited uneven edges, stayed in play amid capability chasms. This is no exception. Just more intense."

"What if the chasm grows unbridgeable?"

"Then we secure our spot to gain from the tech's presence instead of perishing from resisting it."

The session wrapped sans official votes, just guiding aims. Russia would watch, adjust, and steer clear of clashes with untamable powers.

***

# Middle East

The secluded advisory hall in a Gulf city housed folks whose fortunes hit billions and sway spanned nations. They gathered rarely, solely for true weighty matters.

Medical nanites fit the bill.

The most senior, from a lineage gripping vast assets over three eras, addressed with the poise born of weathering oil slumps and local wars. "Our stance rests on three bases: resource riches, prime spot, and grabbing any tech cash can claim. Nova Technologies strikes right at the last base."

"They're not peddling entry," a voice noted. "The Lucid gadget uses lotteries. Funds don't lock in spots."

"That's exactly the snag. We're used to arenas where money opens doors. This arena sidelines money for the door key. Our fortunes yield zero edge in snagging the core tech for these nanites."

A fresher face, schooled in London and tied to fresh fortunes, displayed breakdowns on his pad. "The sub plan is rather open. Sovereign level's just $60,000 a year. Pocket change. The wall isn't price after entry. It's breaching the circle to begin with."

"Thus, we require Lucid gadgets."

"We require them for us, kin, vital staff. Yet the reserve setup blocks that hard. Ten thousand worldwide next month. Millions chasing. Even top net setups money funds, chances stink."

"Any other ways to get them?" The ask came guarded, worded to nod at options without backing them outright.

"We've checked resale spots. Owners hold tight since steady gains top any lump sum we dangle. We've tried links to Nova via go-betweens. Got courteous brush-offs. We've seen if states could grab for us. The US can't grab for their own."

The elder nodded deliberate. "So we sit equal to the rest. Aiming for draw wins while scheming for flops."

"One more angle," the econ planner tossed in. "Should medical nanites wipe out long ills and stretch vital years far, what of our people edge? We boast youthful crowds. That's a key tool. But if years matter less with folks hale and working forever, we drop that edge against old Western spots who just... halt aging."

"You claim this tech boosts rivals over us."

"I claim it wipes our rare uneven perk while we've no sure grab on the tech doing the wiping."

The group mulled this quietly.

The elder spoke once more. "Our plan has three parts. One, join the trial views. Dispatch top docs to see the tech direct. Two, chase Lucid entry via all fair paths. Three, prep for a world with this tech spread wide, like it or not, 'cause it's arriving."

"What if access slips away?"

"Then we set our heirs to claim it. It's a marathon now."

***

# Singapore

The cabinet update space was tinier than Moscow's or the Gulf's, yet the talk's sharpness rang true to form.

The Trade and Industry head had pored over the news thrice pre-meet. He now tackled the tight cluster of top brass with his usual bluntness. "Nova Technologies spells chance and danger. Chance shines bright: should we turn ourselves into a prime spot for their work, we score econ and strategy wins. Danger matches: fail that, we fade from fields we've built for decades."

The Health head fetched care spending figures. "Our med-tech field pulls near $15 billion yearly. Med travel adds $3 billion more. Both risk hits if nanites work as said. But both offer boons if we turn into Asia-Pacific nanite center."

"That bets Nova seeks such centers," a voice countered.

"It bets we prove vital enough they want us in. We've quick rules. Solid tech setups. Solid rule rep. Those tools we wield."

The Econ Board voice edged in. "Trials are space-bound, but the tech'll need ground spread nets eventually. We pitch as best Asia-Pac base. Grant easy rules. Speed nods. Ease ops here over regional rivals."

"US will match."

"US faces law jams and fifty state rule mazes. We act swift and united."

The Trade and Industry head agreed. "Shape a pitch. Prime spot perks, fast med-tool nods, any perks in our rules. We don't aim to rule Nova. We aim to be their smooth road outward."

"If they shrug?"

"Then we waste just prep hours. But if they bite, we're set for humanity's biggest med-tech rollout. Worth the push."

The session ended with tasks and dates. Singapore would vie not via fights or asks, but by turning essential.

Varied lands, varied plays. Yet same grasp: the globe shifted, and adjusting was sole smart move.

In seventy-two hours post-Medical Nanites unveil, almost all big Earth states reached identical verdicts via unique routes: dispatch watchers to trials, dodge moves eyed as anti-Nova, and start angling to gain from, not fight, a tech beyond their grip, copy, or rule.

China kept its open Lucid ban yet softly probed talk lines. Japan stressed science ties and pitched study links. India aimed for prime future spread spot. Brazil, Canada, Australia, and scores of lesser states filed watch bids with worded notes owning the tech's weight sans yielding rule power they'd lost grip on.

The trend spanned all: adjust, watch, pray ties yield pull that clashes clearly wouldn't. No state picked fight, as every plan—be it arms worry, money gain, or org ego—deemed battling a space-backed, law-bending group while denying wanted boons led to fade at mildest, doom at worst.